FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2265758081> ?p ?o ?g. }

• W2265758081 endingPage "e0147183" @default.
• W2265758081 startingPage "e0147183" @default.
• W2265758081 abstract "Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The Km and Vmax values of CK were 84.20±21.92 μM and 0.28±0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63±10.48 μM and 0.45±0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03±5.04 μM and 0.68±0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 μM and 9.83 μM, and Ki values were 14.92 μM and 11.42μM for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors." @default.
• W2265758081 created "2016-06-24" @default.
• W2265758081 creator A5006416068 @default.
• W2265758081 creator A5019601788 @default.
• W2265758081 creator A5019739018 @default.
• W2265758081 creator A5020692883 @default.
• W2265758081 creator A5036106232 @default.
• W2265758081 creator A5047932271 @default.
• W2265758081 creator A5057724465 @default.
• W2265758081 creator A5061500406 @default.
• W2265758081 creator A5066346724 @default.
• W2265758081 creator A5078465675 @default.
• W2265758081 creator A5085515243 @default.
• W2265758081 date "2016-02-04" @default.
• W2265758081 modified "2023-10-18" @default.
• W2265758081 title "Screening of Drug Metabolizing Enzymes for the Ginsenoside Compound K In Vitro: An Efficient Anti-Cancer Substance Originating from Panax Ginseng" @default.
• W2265758081 cites W125536496 @default.
• W2265758081 cites W1723026707 @default.
• W2265758081 cites W1860026848 @default.
• W2265758081 cites W1880062250 @default.
• W2265758081 cites W1907838830 @default.
• W2265758081 cites W1965180872 @default.
• W2265758081 cites W1979431461 @default.
• W2265758081 cites W1997271604 @default.
• W2265758081 cites W2003265614 @default.
• W2265758081 cites W2005807722 @default.
• W2265758081 cites W2023846838 @default.
• W2265758081 cites W2027156167 @default.
• W2265758081 cites W2032412826 @default.
• W2265758081 cites W2055318533 @default.
• W2265758081 cites W2056725127 @default.
• W2265758081 cites W2061694980 @default.
• W2265758081 cites W207907705 @default.
• W2265758081 cites W2085737366 @default.
• W2265758081 cites W2100539109 @default.
• W2265758081 cites W2106909698 @default.
• W2265758081 cites W2120700977 @default.
• W2265758081 cites W2122692346 @default.
• W2265758081 cites W2124662083 @default.
• W2265758081 cites W2152415731 @default.
• W2265758081 cites W2168361614 @default.
• W2265758081 cites W2320287751 @default.
• W2265758081 cites W2340940993 @default.
• W2265758081 cites W823195 @default.
• W2265758081 doi "https://doi.org/10.1371/journal.pone.0147183" @default.
• W2265758081 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4742234" @default.
• W2265758081 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26845774" @default.
• W2265758081 hasPublicationYear "2016" @default.
• W2265758081 type Work @default.
• W2265758081 sameAs 2265758081 @default.
• W2265758081 citedByCount "19" @default.
• W2265758081 countsByYear W22657580812016 @default.
• W2265758081 countsByYear W22657580812017 @default.
• W2265758081 countsByYear W22657580812018 @default.
• W2265758081 countsByYear W22657580812019 @default.
• W2265758081 countsByYear W22657580812020 @default.
• W2265758081 countsByYear W22657580812021 @default.
• W2265758081 countsByYear W22657580812022 @default.
• W2265758081 countsByYear W22657580812023 @default.
• W2265758081 crossrefType "journal-article" @default.
• W2265758081 hasAuthorship W2265758081A5006416068 @default.
• W2265758081 hasAuthorship W2265758081A5019601788 @default.
• W2265758081 hasAuthorship W2265758081A5019739018 @default.
• W2265758081 hasAuthorship W2265758081A5020692883 @default.
• W2265758081 hasAuthorship W2265758081A5036106232 @default.
• W2265758081 hasAuthorship W2265758081A5047932271 @default.
• W2265758081 hasAuthorship W2265758081A5057724465 @default.
• W2265758081 hasAuthorship W2265758081A5061500406 @default.
• W2265758081 hasAuthorship W2265758081A5066346724 @default.
• W2265758081 hasAuthorship W2265758081A5078465675 @default.
• W2265758081 hasAuthorship W2265758081A5085515243 @default.
• W2265758081 hasBestOaLocation W22657580811 @default.
• W2265758081 hasConcept C109650736 @default.
• W2265758081 hasConcept C119795356 @default.
• W2265758081 hasConcept C140027455 @default.
• W2265758081 hasConcept C142724271 @default.
• W2265758081 hasConcept C181199279 @default.
• W2265758081 hasConcept C185592680 @default.
• W2265758081 hasConcept C196013638 @default.
• W2265758081 hasConcept C202751555 @default.
• W2265758081 hasConcept C204787440 @default.
• W2265758081 hasConcept C2776658834 @default.
• W2265758081 hasConcept C2777752497 @default.
• W2265758081 hasConcept C2779232237 @default.
• W2265758081 hasConcept C33664856 @default.
• W2265758081 hasConcept C3946865 @default.
• W2265758081 hasConcept C526171541 @default.
• W2265758081 hasConcept C55493867 @default.
• W2265758081 hasConcept C71924100 @default.
• W2265758081 hasConcept C86745063 @default.
• W2265758081 hasConcept C86803240 @default.
• W2265758081 hasConcept C87644729 @default.
• W2265758081 hasConcept C89311334 @default.
• W2265758081 hasConcept C98274493 @default.
• W2265758081 hasConceptScore W2265758081C109650736 @default.
• W2265758081 hasConceptScore W2265758081C119795356 @default.
• W2265758081 hasConceptScore W2265758081C140027455 @default.
• W2265758081 hasConceptScore W2265758081C142724271 @default.

• next